Efficacy of First Line Dexamethasone, Rituximab and Cyclophosphamide (DRC) +/- Bortezomib for Patients With Waldenstrom's Macroglobulinemia
Phase of Trial: Phase III
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Dexamethasone; Rituximab
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 25 Oct 2016 This trial was suspended in Greece, according to European Clinical Trials Database.
- 20 Oct 2016 This trial was suspended in Portugal, according to European Clinical Trials Database.
- 10 Sep 2015 Final Results published in the Blood (letter).